"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
The amounts of zinc, copper, chromium and manganese in Pedtrace (zinc, copper, manganese and chromium intravenous solution) ®-4 are very small and toxicity symptoms due to these trace elements at suggested dosage levels are considered unlikely to occur.
DRUG ABUSE AND DEPENDENCE
Read the Pedtrace (zinc, copper, manganese and chromium intravenous solution) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Pedtrace Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.